A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Cost variations among gastric acid lowering medications used for treatment of Gastroesophageal Reflux Disease (GERD)
2018
Asian Journal of Pharmacy and Pharmacology
Objective: Objective of the study was to conduct cost variations among marketed pharmaceutical brands for two drug classes which are prescribed for the treatment of Gastroesophageal Reflux Disease (GERD) viz Histamine H 2 Receptor antagonists (H A) and Proton Pump Inhibitors (PPI). Two acid lowering drugs 2 Materials and Methods: classes manufactured by the different Indian pharmaceutical industries were analysed for the cost variation. In this study, two authors has collected the data of the
doi:10.31024/ajpp.2018.4.4.12
fatcat:gieexftenzfwpf5wtowhlmnggy